Doctor profile · Federal record
Dr. Kathe Bryson, M.D.
Rheumatology Physician (CMS: Rheumatology) · Erie, PA
- NPI 1043206303
- Accepts Medicare
- MIPS 92.0 / 100 · 2023
- 33 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
3317 Liberty St
Erie, PA 165082558
(814) 868-8531
fax (814) 866-1439
Credentials & registration
- NPI registered
- September 2005 — 21 yrs on file
- Profile last updated
- July 8, 2007
- Year of graduation
- 1993 — 33 yrs since
- Specialty taxonomy
- 207RR0500X — NUCC code
- State license (1)
- Pennsylvania #MD056946L
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1043206303. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
121,945
Distinct HCPCS
10
Medicare allowed
$1,048,413
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0717 |
Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 95,600 | 26 | $5 | |
J1602 |
Injection, golimumab, 1 mg, for intravenous use | 17,810 | 18 | $13 | |
J1745 |
Injection, infliximab, excludes biosimilar, 10 mg | 4,050 | 11 | $33 | |
J0897 |
Injection, denosumab, 1 mg | 2,520 | 28 | $23 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 593 | 334 | $85 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 564 | 279 | $121 | |
96372 |
Injection of drug or substance under skin or into muscle | 298 | 70 | $13 | |
96365 |
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 258 | 42 | $58 | |
96366 |
Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 113 | 16 | $18 | |
J1040 |
Injection, methylprednisolone acetate, 80 mg | 56 | 36 | $12 |
In context: peer comparison
Among 3 peers in this city , average services per provider: 8,936. This provider delivers 14× the peer median.Open Payments
Industry payments received
All-time total
$1,530
Transactions
90
Manufacturers
11
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Janssen Biotech, Inc. | 28 | $629.36 | |
| Amgen Inc. | 9 | $210.58 | |
| PFIZER INC. | 16 | $181.56 | |
| ABBVIE INC. | 22 | $167.97 | |
| UCB, Inc. | 3 | $93.61 | |
| Novartis Pharmaceuticals Corporation | 4 | $88.50 | |
| AstraZeneca Pharmaceuticals LP | 2 | $47.74 | |
| Mallinckrodt Hospital Products Inc. | 2 | $41.33 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $36.20 | |
| Fresenius Kabi USA, LLC | 1 | $17.94 | |
| GlaxoSmithKline, LLC. | 1 | $15.11 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
3,735
Patients
947
Total drug cost
$671,991
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate | Generic | 992 | 264 | $70,857 |
| Prednisone | Generic | 702 | 195 | $7,857 |
| Methotrexate (Methotrexate Sodium) | Brand | 696 | 173 | $25,062 |
| Leflunomide | Generic | 262 | 77 | $23,378 |
| Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) | Brand | 180 | 22 | $3,928 |
| Tramadol Hcl | Generic | 170 | 31 | $1,388 |
| Meloxicam | Generic | 148 | 43 | $954 |
| Azathioprine | Generic | 114 | 24 | $7,168 |
| Folic Acid | Generic | 87 | 25 | $452 |
| Celecoxib | Generic | 81 | 19 | $4,681 |
Hospital affiliations
Frequently asked questions
What is Dr. Kathe Bryson's medical specialty?
Dr. Kathe Bryson practices Rheumatology Physician in Erie, PA.
Where does Dr. Kathe Bryson practice?
Dr. Kathe Bryson practices at 3317 Liberty St, Erie, PA 165082558. Office phone: 8148688531.
What is Dr. Kathe Bryson's NPI?
Dr. Kathe Bryson's National Provider Identifier (NPI) is 1043206303, issued by NPPES.
Does Dr. Kathe Bryson accept Medicare assignment?
Yes. Dr. Kathe Bryson accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Kathe Bryson commonly perform?
Top Medicare-reported procedures in 2023: Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0717); Injection, golimumab, 1 mg, for intravenous use (HCPCS J1602); Injection, infliximab, excludes biosimilar, 10 mg (HCPCS J1745). Source: CMS Medicare Physician & Other Practitioners file.